IOL Chemicals and Pharmaceuticals Limited Submits Compliance Certificate for SDD for Q4 FY26
IOL Chemicals and Pharmaceuticals Limited submitted its compliance certificate for the quarter ended March 31, 2026, regarding its Structured Digital Database (SDD). The company confirmed it has a compliant SDD in place, capturing all UPSI and maintaining an audit trail for eight years.
This is a standard regulatory filing related to insider trading compliance. It does not introduce any new material information that would significantly impact the company's stock or operations.
The announcement is a routine compliance filing regarding the Structured Digital Database and does not contain any new financial information or significant business developments that would warrant a positive or negative sentiment.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has submitted a compliance certificate for the quarter ended March 31, 2026, regarding its Structured Digital Database (SDD). The certificate, issued as per SEBI's Prohibition of Insider Trading Regulations, 2015, confirms that the company maintains a compliant SDD.
According to the certificate signed by Abhay Raj Singh, Sr. Vice President & Company Secretary, the company has a functional SDD with controlled access. All Unpublished Price Sensitive Information (UPSI) disseminated in the previous quarter has been captured with the correct nature, date, and time. The database is maintained internally with an audit trail, is non-tamperable, and can retain records for eight years. IOLCP successfully captured 1 event during the quarter as required.
The company reported no non-compliance issues in the previous quarter, and consequently, no remedial actions were necessary. The certificate was dated April 17, 2026, and issued from Ludhiana.
What to do with a filing like this
IOL Chemicals and Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by IOL Chemicals and Pharmaceuticals Limited. Read the original for the full detail.